Note AB (publ) (NOTE.ST) stock: key figures, P/E, revenue and dividend
Information Technology · Sweden · ISIN SE0001161654
Note AB (publ) financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 3.90 bn SEK | 3.81 bn SEK |
| Gross profit | 519.00 m SEK | 529.00 m SEK |
| EBIT | 386.00 m SEK | 365.00 m SEK |
| Net income | 248.00 m SEK | 281.00 m SEK |
| Diluted EPS – continuing operations | 8.61 SEK | 9.89 SEK |
Full history since 1998, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Note AB (publ)
NOTE AB (publ), together with its subsidiaries, provides electronics manufacturing services in Western Europe and internationally. The company offers manufacturing engineering services in close collaboration with customers, such as component selection, developing test equipment, prototyping, and serial production. It also produces PCBAs, subassemblies, and box build products. In addition, the company provides contract manufacturing, and after-sales services. It serves its products to security and defence, medtech, greentech, industrial, and communication industries. NOTE AB (publ) was incorporated in 1990 and is headquartered in Stockholm, Sweden.
More stocks
- Shenzhen King Brother Electronics Technology Co.Ltd. (301041.SZ)
- Gongwin Biopharm Holdings Co. Ltd. (6617.TWO)
- Elridge Energy Holdings Berhad (0318.KL)
- Hanssem (009240.KS)
- TEJON RANCH CO (TRC)
- Kamada (KMDA)
- POET Technologies Inc (POET)
- LUXFER HOLDINGS PLC (LXFR)
- Ningbo Jianan Electronics Co Ltd (300880.SZ)
- ChinaEtek Service & Technology Co. Ltd. (301208.SZ)
- WABASH NATIONAL Corp (WNC)
- Medigen Vaccine Biologics (6547.TWO)
Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.